Xizang Weixinkang Pharmaceutical Co., Ltd. Class ASSE: 603676

Rectification Report on the Decision of Administrative Supervision Measures by Xizang Office of China Securities Regulatory Commission

· Issued by Xizang Weixinkang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Rectification Report on the Decision of Administrative Supervision Measures by Xizang Office of China Securities Regulatory Commission

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment